Gaucher Disease, Type Iii (GD3)

Gaucher Disease, Type Iii, also known as gaucher disease, subacute neuronopathic type, is related to splenomegaly and gaucher disease, type ii, and has symptoms including apnea, muscle rigidity and muscle spasticity. An important gene associated with Gaucher Disease, Type Iii is GBA1 (Glucosylceramidase Beta 1), and among its related pathways/superpathways are Sphingolipid metabolism and Degradation pathway of sphingolipids, including diseases. The drugs Eliglustat and Pharmaceutical Solutions have been mentioned in the context of this disorder. Affiliated tissues include bone and bone marrow, and related phenotypes are splenomegaly and hepatomegaly